Provided by Tiger Fintech (Singapore) Pte. Ltd.

Evolus Inc.

11.51
-0.0650-0.56%
Volume:243.84K
Turnover:2.78M
Market Cap:731.57M
PE:-14.15
High:11.51
Open:11.41
Low:11.16
Close:11.57
Loading ...

Company Profile

Company Name:
Evolus Inc.
Exchange:
NASDAQ
Establishment Date:
2012
Employees:
332
Office Location:
520 Newport Center Drive,Suite 1200,Newport Beach,California,United States
Zip Code:
92660
Fax:
- -
Introduction:
Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Nuceiva, for the temporary improvement in the appearance of moderate to severe vertical lines between the eyebrows seen at maximum frown. It also provides dermal filler products under the Estyme and Evolysse names. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Directors

Name
Position
David Moatazedi
President, Chief Executive Officer,Director
Vikram Malik
Independent Director,Chairman of the board
Brady Stewart
Independent Director
David Gill
Independent Director
Karah Parschauer
Independent Director
Peter Farrell
Independent Director
Robert Hayman
Independent Director
Simone Blank
Independent Director

Shareholders

Name
Position
David Moatazedi
President, Chief Executive Officer,Director
Sandra Beaver
Chief Financial Officer
Rui Avelar
Chief Medical Officer,Head of Research and Development